American Shared Hospital Services Announces Closing of Acquisition of 60% Majority Interest in Three Radiation Therapy Cancer Centers in Rhode Island

Rhea-AI Summary

American Shared Hospital Services (AMS) has acquired a 60% majority interest in three radiation therapy cancer centers in Rhode Island, adding $9-$10 million in annual revenue with a positive net income contribution. The acquisition more than doubles the revenue backlog to over $210 million, expanding the company's U.S. footprint and product offering.

Positive

• Acquisition adds $9-$10 million in annual revenue with positive net income contribution

• Acquisition more than doubles revenue backlog to over $210 million

• Expands U.S. footprint and product offering

• Projected revenue backlog increases significantly from $106 million in 2021 to an estimated $213 million in May 2024

• Ownership of three Rhode Island radiation therapy cancer centers, two international facilities, and 85% ownership of a third facility ensures revenue generation for at least the next ten years

Negative

• None.

Insights

Financial Analyst

The acquisition of a 60% majority stake in the three Rhode Island cancer treatment centers by American Shared Hospital Services (ASHS) appears to be a strategic expansion, considering the added $9-$10 million in annual revenue and its positive impact on net income. The doubling of the company's revenue backlog to over $210 million is a significant leap from the $106 million reported in 2021. This backlog increment signals to investors a robust pipeline of future revenue, which is critical for long-term growth visibility. The purchase price of $2.85 million suggests that ASHS might be acquiring these assets at a value that could enhance shareholder equity if the revenue and net income projections hold true. However, investors must weigh the operational integration risks and the potential for unforeseen costs associated with the acquisition. Moreover, the strategic locations next to major healthcare systems could mean strengthened partnerships and possibly more referrals, which is beneficial for sustained growth. Considering the positive financial projections and strategic expansions, my rating for this news is 1.

Healthcare Industry Analyst

ASHS's move to secure a majority interest in these radiation therapy centers is a clear indication of its commitment to consolidating its market presence in the United States. Notably, the absence of termination dates on the Rhode Island and international agreements provides a forecast of stable, long-term revenue streams. The acquisition comes off the back of a Chapter 11 bankruptcy of the previous owner, which emphasizes ASHS's opportunistic approach in capitalizing on distressed assets. Their strategy to operate near the second and third largest health systems in Rhode Island could afford them a competitive advantage through potential patient overflow and referrals. Furthermore, the acquisition's endorsement by a prominent figure in the Rhode Island medical community suggests community support and confidence in ASHS's services, which could translate into patient retention and loyalty. From an industry perspective, the expansion of ASHS's footprint is a positive indicator of growth and resilience. My rating for this news is 1.

- Adds $9-$10 million in Annual Revenue with Positive Net Income Contribution -

- Acquisition more than Doubles Backlog to over $210 million -

- Expands U.S. Footprint and Product Offering -

SAN FRANCISCO, May 09, 2024 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy cancer treatment systems and services, today announced the closing of its acquisition of a 60% majority equity interest in the Southern New England Regional Cancer Center, LLC and Roger Williams Radiation Therapy, LLC, both Rhode Island limited liability corporations (the “Companies”) as well as certain payor contracts, from the Chapter 11 Bankruptcy Estate of GenesisCare USA, Inc., a Florida corporation, for a purchase price of $2.85 million.

The Company anticipates this transaction to add $9-$10 million in annual revenue with positive net income contribution. Additionally, the Company announced that its projected revenue backlog has more than doubled to over $210 million with this acquisition.

American Shared estimates that our projected revenue backlog has increased significantly, from $106 million in 2021 to an estimated $213 million in May 2024. Our retail centers are a key factor in this projection, including our acquisition of a 60 percent interest in three Rhode Island radiation therapy cancer centers, along with our current 100 percent ownership of two international facilities in Peru and Ecuador and 85 percent ownership of a third in Mexico. Because the Rhode Island and international agreements have no termination date, we anticipate these centers will generate revenues for at least the next ten years.

The Companies operate three fully functional turn-key radiation therapy cancer centers in Rhode Island, and all three sites are equipped with state-of-the-art cancer treatment technology using Linear Accelerators (LINACs) along with CT Simulators and comprehensive treatment planning software for tumor localization. The Investment interests that were acquired are for facilities that reside on or adjacent to Care New England and Roger Williams Medical Center which are the second and third largest health systems in the State of Rhode Island and are equity members of the subject facilities. The facilities include the Southern New England Regional Cancer Center LLC in Woonsocket, RI and Southern New England Radiation Therapy LLC-Kent in Warwick, RI. The third facility Roger Williams Radiation Therapy LLC is in Providence, RI.

Ray Stachowiak, Executive Chairman of ASHS, commented, “This is a strong milestone for our Company that expands our footprint of owned and operated radiation oncology centers into the U.S. The acquisition adds new revenue streams from each of the three facilities that are accretive to our base and is an excellent use of our capital as we continue to build momentum and execute on our growth strategy. A key to this acquisition is that our ownership preserves the offering of radiation therapy services at the strategically convenient Woonsocket, Providence and Warwick demographic locations. In addition, this ensures patients continued access to community based high quality radiation therapy today and in the future.”

David E. Wazer, MD, Professor and Chairman of Radiation Oncology, Alpert Medical School of Brown University, commented, “It is very fortunate for Rhode Island cancer patients that ASHS was able to step into the void created by the GenesisCare bankruptcy. Had ASHS not taken this action, it is very likely that several treatment facilities would have been closed by the end of year which could have caused severe disruption for the roughly 70 patients per day that receive their care in these facilities. It is not an exaggeration to say that the responsible action by ASHS averted a statewide healthcare emergency.”

Ray Stachowiak continued, “In addition to being a very positive contribution to our company it’s great to have the support of our JV partners, Care New England Health System and Prospect CharterCARE, LLC d/b/a Roger Williams Medical Center. We look forward to growing those relationships and exploring future additional possibilities. The success of these centers is based on the strong local relationships we now have in place and this includes the second and third largest healthcare systems in the state.”

These newly acquired Centers are part of the Seller’s and its affiliates’ Chapter 11 bankruptcy process. The closing of the transaction was subject to certain events and conditions being met including (i) bankruptcy court approval, (ii) approval from the Rhode Island Department of health in accordance with the change in control of the majority member from GenesisCare to American Shared HospitalServices and (iii) other customary closing conditions.

About American Shared Hospital Services (NYSE American: AMS)

American Shared Hospital Services (ASHS) is a leading provider of creative financial and turnkey solutions to Cancer Treatment Centers, hospitals, and large cancer networks worldwide.  The company works closely with all major global Original Equipment Manufacturers (OEMs) that provide leading edge clinical treatment systems and software to treat cancer using Radiation Therapy and Radiosurgery. The company is vendor agnostic and provides financial support for a wide range of products including MR Guided Radiation Therapy Linacs, Advanced Digital Linear Accelerators, Proton Beam Radiation Therapy Systems, Brachytherapy systems and suites, and through the Company’s subsidiary, GK Financing LLC., the Leksell Gamma Knife product and services. For more information, please visit: www.ashs.com

Safe Harbor Statement

This press release may be deemed to contain certain forward-looking statements with respect to the financial condition, results of operations and future plans of American Shared Hospital Services (including statements regarding the expected continued growth of the Company and the expansion of the Company’s Gamma Knife, proton therapy and MR/LINAC business, which involve risks and uncertainties including, but not limited to, the risks of economic and market conditions, the risks of variability of financial results between quarters, the risks of the Gamma Knife and proton therapy businesses, the risks of changes to CMS reimbursement rates or reimbursement methodology, the risks of the timing, financing, and operations of the Company’s Gamma Knife, proton therapy, and MR/LINAC businesses, the risk of expanding within or into new markets, the risk that the integration or continued operation of acquired businesses could adversely affect financial results and the risk that current and future acquisitions may negatively affect the Company’s financial position. Further information on potential factors that could affect the financial condition, results of operations and future plans of American Shared Hospital Services is included in the filings of the Company with the Securities and Exchange Commission, including the Company's Annual Report on Form 10-K for the year ended December 31, 2023, and the definitive Proxy Statement for the Annual Meeting of Shareholders to be held on June 25, 2024.

Contacts:

American Shared Hospital Services
Ray Stachowiak, Executive Chairman and CEO
rstachowiak@ashs.com

Investor Relations

Kirin Smith, President
PCG Advisory, Inc.
ksmith@pcgadvisory.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/7aa17d06-4f9e-4955-881d-8ecb06af5b1d